tiprankstipranks
Trending News
More News >
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO

Spero Therapeutics (SPRO) Revenue

Compare
519 Followers

Spero Therapeutics Revenue

Spero Therapeutics had a revenue of 13.47M in the quarter ending Sep 30, 2024, with 123.85%. This bring the company's revenue in the last twelve months to 95.52M, Increased -11.16%. In the fiscal year ending Dec 31, 2024, Spero Therapeutics had annual revenue of 47.98M with -50.40% growth.
Revenue (ttm)
95.52M
Revenue Growth
-71.68%
P/S Ratio
0.70
Revenue/Employee
$1,499,281
Employees
32
Market Cap
$33.54M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202447.98M-48.76M-50.40%
Dec 31, 202396.73M48.16M+99.13%
Dec 31, 202248.58M30.32M+166.10%
Dec 31, 202118.26M8.93M+95.67%
Dec 31, 20209.33M4.59M+96.75%
Dec 31, 20194.74M776.00K+19.57%
Dec 31, 20183.97M1.99M+100.40%
Dec 31, 20171.98M1.64M+490.75%
Dec 31, 2016335.00K+∞%
Dec 31, 20150.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis